Table 2.
Spearman rank correlations between plasma TMAO and variables in T2DM patients
| Variables | Plasma TMAO concentrations, µmol/L | |
|---|---|---|
| R | P | |
| Age, year | 0.314 | < 0.001 |
| BMI, kg/m2 | 0.131 | 0.151 |
| Diabetes duration, year | 0.233 | 0.010 |
| Triglyceride, mmol/L | 0.000 | 0.999 |
| TC, mmol/L | − 0.097 | 0.290 |
| HDL-C, mmol/L | − 0.046 | 0.614 |
| LDL-C, mmol/L | − 0.097 | 0.286 |
| SCr, mg/dL | 0.393 | < 0.001 |
| eGFR, mL/min/1.73 m2 | − 0.528 | < 0.001 |
TMAO trimethylamine-N-oxide; T2DM, type 2 diabetes mellitus; BMI, body mass index; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; SCr, serum creatinine; eGFR, estimated glomerular filtration rate